Anti-inflammatory agents and renal functionBRATER, D. Craig.Seminars in arthritis and rheumatism. 2002, Vol 32, Num 3, pp 33-42, issn 0049-0172, 10 p., SUP1Article

Measurement of renal function during drug developmentBRATER, D. Craig.British journal of clinical pharmacology. 2002, Vol 54, Num 1, pp 87-95, issn 0306-5251Conference Paper

Loop diuretics: from the Na-K-2Cl transporter to clinical useSHANKAR, Sudha S; BRATER, D. Craig.American journal of physiology. Renal physiology. 2003, Vol 53, Num 1, pp F11-F21, issn 1931-857XArticle

Renal effects of cyclooxygyenase-2-selective inhibitors. CommentaryBRATER, D. Craig; WEIR, Matthew R.Journal of pain and symptom management. 2002, Vol 23, Num 4, pp S15-S23, issn 0885-3924, SUPConference Paper

Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal studyMACFADYEN, Robert J; GORSKI, J. Christopher; BRATER, D. Craig et al.British journal of clinical pharmacology. 2004, Vol 57, Num 5, pp 622-631, issn 0306-5251, 10 p.Article

Renal effects of COX-2-selective inhibitorsBRATER, D. Craig; HARRIS, Cynthia; REDFERN, Jan S et al.American journal of nephrology. 2001, Vol 21, Num 1, pp 1-15, issn 0250-8095Article

Reliability and validity of the compliance belief scales among patients with heart failureBENNETT, Susan J; PERKINS, Susan M; LANE, Kathleen A et al.Heart & lung. 2001, Vol 30, Num 3, pp 177-185, issn 0147-9563Article

Association between adherence to diuretic therapy and health care utilization in patients with heart failureCHUI, Michelle A; DEER, Melissa; BENNETT, Susan J et al.Pharmacotherapy. 2003, Vol 23, Num 3, pp 326-332, issn 0277-0008, 7 p.Article

Pharmacist intervention to improve medication adherence in heart failure : A randomized trialMURRAY, Michael D; YOUNG, James; GRADUS-PIZLO, Irmina et al.Annals of internal medicine. 2007, Vol 146, Num 10, pp 714-725, issn 0003-4819, 12 p.Article

BG9719 (CVT-124), an A₁ adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapyGOTTLIEB, Stephen S; BRATER, D. Craig; BECKMAN, Evan et al.Circulation (New York, N.Y.). 2002, Vol 105, Num 11, pp 1348-1353, issn 0009-7322Article

Open-label randomized trial of torsemide Compared with furosemide therapy for patients with heart failureMURRAY, Michael D; DEER, Melissa M; BRATER, D. Craig et al.The American journal of medicine. 2001, Vol 111, Num 7, pp 513-520, issn 0002-9343, 577 [9 p.]Article

A Randomized, Double-Blind, Safety and Tolerability Study to Assess the Ophthalmic and Renal Effects of Tafenoquine 200 mg Weekly versus Placebo for 6 Months in Healthy VolunteersLEARY, Kevin J; RIEL, Michael A; BEBOSO, Ronnie et al.The American journal of tropical medicine and hygiene. 2009, Vol 81, Num 2, pp 356-362, issn 0002-9637, 7 p.Article

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib : results from the MEDAL studyKRUM, Henry; SWERGOLD, Gary; CURTIS, Sean P et al.Journal of hypertension. 2009, Vol 27, Num 4, pp 886-893, issn 0263-6352, 8 p.Article

Association between adherence measurements of metoprolol and health care utilization in older patients with heart failureWANZHU TU; MORRIS, Andrew B; JINGJIN LI et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 3, pp 189-201, issn 0009-9236, 13 p.Article

Controversies in COX-2 selective inhibitionSIMON, Lee S; SMOLEN, Josef S; DOUGADOS, Maxime et al.Journal of rheumatology. 2002, Vol 29, Num 7, pp 1501-1510, issn 0315-162XArticle

Health care and medication costs and use among older adults with Heart failureSTROUPE, Kevin T; TEAL, Evgenia Y; WEINER, Michael et al.The American journal of medicine. 2004, Vol 116, Num 7, pp 443-450, issn 0002-9343, 8 p.Article

Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacyHIATT, William R; HIRSCH, Alan T; COOKE, John P et al.Vascular medicine (London). 2004, Vol 9, Num 1, pp 18-25, issn 1358-863X, 8 p.Article

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intakeHULEDAL, Gunilla; JONZON, Bror; MALMENÄS, Maria et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 5, pp 437-450, issn 0009-9236, 14 p.Article

Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patientsCHALASANI, Naga; GORSKI, J. Christopher; HORLANDER, John C et al.Journal of the American Society of Nephrology. 2001, Vol 12, Num 5, pp 1010-1016, issn 1046-6673Article